ERBB2 and breast cancer: Females ≥50 yearsUnifocal primary breast cancer ≤1.5 cmInvasive ductal breast carcinomaNottingham grade 1-2 (nuclear/mitotic score <2)ER+, PR+, HER2-Lesion visible on ultrasound at time of treatmentNo previous ipsi/contralateral breast carcinoma